Clinical Trials Browser

Esophageal Neoplasms

Anus Neoplasms, Rectal Neoplasms, HIV Infections

Stomach Neoplasms

Stomach Neoplasms

Pancreatic Neoplasms

Esophageal Neoplasms, Stomach Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Anal Canal Carcinoma, Anus Neoplasms

Pancreatic Neoplasms

Liver Metastases From Colorectal Cancer (mCRC)

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Rectal Neoplasms

Adenocarcinoma Of Esophagus, Neoplasm Metastasis, Stomach Neoplasms

Cholangiocarcinoma

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Gallbladder Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Adenocarcinoma, Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

Stomach Neoplasms

Small Bowel Adenocarcinoma

Locally Advanced Pancreatic Cancer

HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma

Biliary Tract Neoplasms, Stomach Neoplasms

Colorectal Neoplasms

Stomach Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Colonic Neoplasms

Pancreatic Neoplasms

Esophageal Neoplasms

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma, Klatskin Tumor

Biliary Tract Neoplasms, Gastrointestinal Neoplasms

Rectal Neoplasms

Colorectal Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Rectal Neoplasms, Colorectal Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Colorectal Cancer Metastatic

Pancreatic Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Pancreatic Neoplasms

Colorectal Cancer Metastatic

Klatskin Tumor

Colorectal Neoplasms

Pancreatic Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Carcinoma, Pancreatic Neoplasms

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

Carcinoma, Hepatocellular

Stomach Neoplasms

Clinical Trials

PROTECT

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

PANCREAS

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

EDGE-Gastric

Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

DG-03

TOGAR

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

TRIPP-FFX

Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

ERASE-CRC

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA

NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer

A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer

A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

CANTOR

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

PANC

Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver

HAITI

Pancreas

Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab

Biliary Drainage Plus HAIC in Locally Advanced pCCA

CEIL

Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer

Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer

Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer

NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer

GRACIE

Hepatic Arterial Infusion Chemotherapy With Lipiodol Embolization in Advanced Hepatocellular Carcinoma

Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions